Double hit lymphoma: from biology to therapeutic implications
Gestores bibliográficos
Compartir
item.contributor.advisor
ORCID:
Journal Title
Journal ISSN
Volume Title
Publisher
Taylor & Francis Online
item.page.isbn
item.page.issn
item.page.issne
item.page.doiurl
item.page.extent
10
item.page.accessRights
item.page.other
item.page.references
Abstract
INTRODUCTION:
Diffuse large B-cell lymphoma (DLBCL) is a molecularly heterogeneous disease defined by different cellular origins and mechanisms of oncogenic activation. Approximately 10% of DLBCL case...
Description
item.page.coverage.spatial
item.page.sponsorship
Citation
Expert Rev Hematol. 2016 Jul;9(7):669-78
Keywords
BCL2 , BCL2 inhibitors , BCL6 , DHL , DPE , Double-hit , MYC , MYC inhibitors , double-expresser , triple-hit
item.page.dc.rights
item.page.dc.rights.url
Estadísticas de uso
1 0,8 0,5 0,3 0
Septiembre 2025Octubre 2025Noviembre 2025Diciembre 2025Enero 2026Febrero 2026Marzo 2026